United States · FDA National Drug Code directory

bisoprolol fumarate and hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-0595_83e47e72-5cf3-4db5-902e-20d7d9595cb9
Product NDC
71335-0595
Form
TABLET
Composition / generic term
bisoprolol fumarate and hydrochlorothiazide
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20101012
Source listing expiry
20261231

Source-listed ingredients

  • HYDROCHLOROTHIAZIDE — 6.25 mg/1
  • BISOPROLOL FUMARATE — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE, PLASTIC (71335-0595-1) · 71335-0595-1
  • 90 TABLET in 1 BOTTLE, PLASTIC (71335-0595-2) · 71335-0595-2
  • 28 TABLET in 1 BOTTLE, PLASTIC (71335-0595-3) · 71335-0595-3
  • 100 TABLET in 1 BOTTLE, PLASTIC (71335-0595-4) · 71335-0595-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →